This week, we highlight an Open Pharma case study in Informa’s 2023 sustainability report and feature new guidance from DORA on the use of quantitative indictors of research quality. We read about a new 3-year partnership between the EQUATOR Network and COS, and about the transition of Learned Publishing to a gold OA model. We also read a summary of the first day of the ISMPP Annual Meeting and revisit the 2024 R2R Conference. Finally, we signpost a webinar exploring whether OA is truly open for all.
To read:
2023 Informa sustainability report via Informa | 2-hour read
Informa – the parent company of Taylor & Francis – has released its 2023 sustainability report. The report, which summarizes progress towards the company’s Faster Forward initiative, features a case study of Taylor & Francis’s support of Open Pharma. Written by Liz Knowles (Global Portfolio Director, Medicine & Health at Taylor & Francis), the case study calls on other publishers to join Open Pharma and contribute their valuable perspectives to our work reshaping the future of pharma research communication.
DORA guidance on research indicators via DORA | 2-minute read
The Declaration on Research Assessment (DORA) – a prominent critic of the journal impact factor as a measure of research quality – has released a new guidance document about how to use quantitative indicators responsibly for research assessment. The guidance outlines the limitations of popular research indicators and identifies five principles that can prevent indicators from being misused when assessing research quality. The full guidance document is available to download via DORA and Zenodo.a
EQUATOR Network and COS announce partnership via EQUATOR Network | 3-minute read
The EQUATOR Network and the Center for Open Science (COS) have announced a 3-year partnership to improve the quality and clarity of published research. The partnership aims to advance the missions of both organizations through educational outreach, the development of practical toolkits, and the co-hosting of resources on each other’s platforms. Additional information about the partnership is available via the EQUATOR Network.a
Learned Publishing transitions to gold OA model via ALPSP | 1-minute read
The Association of Learned and Professional Society Publishers (ALPSP) journal Learned Publishing will transition to a gold open access (OA) model in 2025. The announcement is accompanied by the news that the ALPSP Board will cover article processing charges for authors who are ALPSP members. More information about the transition – which is supported by ALPSP’s publishing partner Wiley – can be found in this press release.
ISMPP Annual Meeting day one summary via The Publication Plan | 19-minute read
Taking place from 29 April to 1 May in Washington, DC, the 2024 Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) focused on Storytelling: its art and power. This summary from The Publication Plan provides an overview of day one of the meeting, which included sessions on patient engagement in publication, the role of scientific communication platforms and the use of publication metrics. Read more about Open Pharma’s presence at the meeting in last week’s digest.
R2R Conference recap via The Scholarly Kitchen | 7-minute read
Missed the 2024 Researcher to Reader (R2R) Conference? No problem! This guest post for The Scholarly Kitchen revisits the meeting’s closing summary as presented by Heather Staines (Director of Community Engagement and Senior Consultant at Delta Think). A recording of the presentation is also available on YouTube.
To watch:
Open for all? via Karger | 1.5-hour watch
Is OA really open to everyone? Watch panellists Roger Schonfeld (Vice President at Ithaka), Beth Montague-Hellen (Head of Library and Information Services at The Francis Crick Institute), Hannah Hope (Open Research Lead at Wellcome) and Sarah Wettstadt (Science Communication Manager at the Scientific Panel on Responsible Plant Nutrition) discuss the extent to which OA reaches diverse audiences, the impact of OA on medical research communications and more.
Enjoy reading our content? Then make sure to follow us on Twitter/X and LinkedIn for regular updates!
aPaige – a generative AI tool created by Oxford PharmaGenesis – was used to create an early draft of this summary. Paige uses OpenAI’s GPT Large Language Models, securely and privately accessed from within Microsoft’s Azure platform. The AI-generated output was reviewed, modified or rewritten, and checked for accuracy by at least one member of the Open Pharma team. The news pieces included in the weekly digest are curated by the Open Pharma team without the use of AI.
